Zhaohui Ni, Haijiao Jin, Renhua Lu, Lihong Zhang, Li Yao, Guojian Shao, Li Zuo, Shuguang Qin, Xinzhou Zhang, Qinghong Zhang, Weimin Yu, Qun Luo, Yuqing Ren, Hui Peng, Jie Xiao, Qiongqiong Yang, Qinkai Chen, Yifan Shi
BACKGROUND: Hyperkalaemia is a known risk factor for cardiac arrhythmia and mortality in patients on haemodialysis. Despite standard adequate haemodialysis, hyperkalaemia is common in patients with end-stage renal disease (ESRD) at interdialytic intervals. Data on hyperkalaemia burden and its effects on dialysis patterns and serum potassium (sK) fluctuations in patients on haemodialysis in China remain limited. The prospective, observational cohort study (PRECEDE-K; NCT04799067) investigated the prevalence, recurrence, and treatment patterns of hyperkalaemia in Chinese patients with ESRD on haemodialysis...
August 9, 2023: BMC Nephrology